The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
Abstract
The old herbal drug aristolochic acid (AA), derived from Aristolochia spp., has been associated with the development of a novel nephropathy, designated aristolochic acid nephropathy (AAN), and urothelial cancer in AAN patients. There is clear evidence that the major components of the plant extract AA, aristolochic acid I (AAI) and aristolochic acid II (AAII), both nitrophenanthrene carboxylic acids, are genotoxic mutagens forming DNA adducts after metabolic activation through simple reduction of the nitro group. Several mammalian enzymes have been shown to be capable of activating both AAI and AAII in vitro and in cells. The activating metabolism has been elucidated and is consistent with the formation of a cyclic nitrenium ion with delocalized charge leading to the preferential formation of purine adducts bound to the exocyclic amino groups of deoxyadenosine and deoxyguanosine. The predominant DNA adduct in vivo, 7-(deoxyadenosin-N(6)-yl)aristolactam I (dA-AAI), which is the most persistent of the adducts in target tissue, is a mutagenic lesion leading to AT-->TA transversions in vitro. This transversion mutation is found at high frequency in codon 61 of the H-ras oncogene in tumours of rodents induced by AAI, suggesting that dA-AAI might be the critical lesion in the carcinogenic process in rodents. DNA-binding studies confirmed that both AAs bind to the adenines of codon 61 in the H-ras mouse gene and preferentially to purines in the human p53 gene. In contrast, the molecular mechanism of renal interstitial fibrosis in humans after chronic administration of AA remains to be explored. However, preliminary findings suggest that DNA damage by AA is not only responsible for the tumour development but also for the destructive fibrotic process in the kidney. It is concluded that there is significant evidence that AA is a powerful nephrotoxic and carcinogenic substance with an extremely short latency period, not only in animals but also in humans. In particular, the highly similar metabolic pathway of activation and resultant DNA adducts of AA allows the extrapolation of carcinogenesis data from laboratory animals to the human situation. Therefore, all products containing botanicals known to or suspected of containing AA should be banned from the market world wide.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Greenblatt, M. S., Bennett, W. P., Hollstein, M., & Harris, C. C. (1994) · PubMed · Cited by 3,463
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Vanherweghem, J.-L., Tielemans, C., Abramowicz, D., Depierreux, M., Vanhaelen-Fastre, R., Vanhaelen, M., Dratwa, M., Richard, C., Vandervelde, D., Verbeelen, D., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92984-2 · Cited by 1,076
Environment and Cancer: Who Are Susceptible?
Perera, F. P. (1997) · Science · doi:10.1126/science.278.5340.1068 · Cited by 638
Mutagenicity of Nitroaromatic Compounds
Purohit, V., & Basu, A. K. (2000) · Chemical Research in Toxicology · doi:10.1021/tx000002x · Cited by 450
Hussain, S. P., & Harris, C. C. (1998) · PubMed · Cited by 407
Oncogene Activation in Chemical Carcinogenesis
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 388
Identification of aristolochic acid in Chinese herbs
Vanhaelen, M., Vanhaelen-Fastre, R., But, P., & Vanherweghem, J.-L. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90964-4 · Cited by 344
Urothelial lesions in Chinese-herb nephropathy
Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., Wese, F.-X., & van Ypersele de Strihou, C. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70136-8 · Cited by 306
Chinese herbs nephropathy: A clue to Balkan endemic nephropathy?
Cosyns, J.-P., Jadoul, M., Squifflet, J.-P., de Plaen, J.-F., Ferluga, D., & Van Ypersele de Strihou, C. (1994) · Kidney International · doi:10.1038/ki.1994.220 · Cited by 297
Schmeiser, H. H., Bieler, C. A., Wießler, M., de Strihou, C. V. Y., & Cosyns, J. P. (1996) · PubMed · Cited by 272
Aristolochic Acids Induce Chronic Renal Failure with Interstitial Fibrosis in Salt-Depleted Rats
Debelle, F. A. A. A. A. D., Nortier, J. D. L., De Prez, E. G., Garbar, C. H., Vienne, A. R., Salmon, I. J., Deschodt-Lanckman, M. M., & Vanherweghem, J.-L. (2002) · Journal of the American Society of Nephrology · doi:10.1681/asn.v132431 · Cited by 268
Nephropathy caused by Chinese herbs in the UK
Lord, G. M., Tagore, R., Cook, T., Gower, P., & Pusey, C. D. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03380-2 · Cited by 264
Pathologic Aspects of a Newly Described Nephropathy Related to the Prolonged Use of Chinese Herbs
Depierreux, M., Van Damme, B., Vanden Houte, K., & Vanherweghem, J. L. (1994) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80178-8 · Cited by 260
DNA adducts of chemical carcinogens
Dipple, A. (1995) · Carcinogenesis · doi:10.1093/carcin/16.3.437 · Cited by 255
Vanherweghem, J.-L. (1998) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1998.4.1-9 · Cited by 225
Chronic aristolochic acid toxicity in rabbits: A model of Chinese herbs nephropathy?
Cosyns, J.-P., Dehoux, J.-P., Guiot, Y., Goebbels, R.-M., Robert, A., Bernard, A. M., & Van Ypersele De Strihou, C. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00731.x · Cited by 162
Site-specific mutagenesis: retrospective and prospective
Singer, B. C., & Essigmann, J. M. (1991) · Carcinogenesis · doi:10.1093/carcin/12.6.949 · Cited by 145
SOS induction of selected naturally occurring substances in Escherichia coli (SOS chromotest)
Kevekordes, S., Mersch‐Sundermann, V., Burghaus, C. M., Spielberger, J., Schmeiser, H. H., Arlt, V. M., & Dunkelberg, H. (1999) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(99)00141-2 · Cited by 139
Self-citationTumour induction in mice following exposure to aristolochic acid
Mengs, U. (1988) · Archives of Toxicology · doi:10.1007/bf00293699 · Cited by 123
Stiborová, M., Frei, E., Wießler, M., & Schmeiser, H. H. (2001) · Chemical Research in Toxicology · doi:10.1021/tx010059z · Cited by 119
Aristolochic acid activates ras genes in rat tumors at deoxyadenosine residues.
Schmeiser, H. H., Janssen, J. W. G., Lyons, J., Scherf, H. R., Pfau, W., Buchmann, A., Bartram, C. R., & Wießler, M. (1990) · PubMed · Cited by 117
Mengs, U., & Stotzem, C. D. (1993) · Archives of Toxicology · doi:10.1007/bf01973700 · Cited by 112
The Aristolochic Acids and Aristolactams
Mix, D. B., Guinaudeau, H., & Shamma, M. (1982) · Journal of Natural Products · doi:10.1021/np50024a001 · Cited by 112
Chinese herbs nephropathy presentation, natural history and fate after transplantation
Reginster, F., Jadoul, M. Y., & de Strihou, C. V. Y. (1997) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/12.1.81 · Cited by 107
Vanherweghem, J., Abramowicz, D., Tielemans, C. L., & Depierreux, M. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90542-9 · Cited by 98
Aristolochic acid impedes endocytosis and induces DNA adducts in proximal tubule cells
Lebeau, C., Arlt, V. M., Schmeiser, H. H., Boom, A., Verroust, P. J., Devuyst, O., & Beauwens, R. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00938.x · Cited by 95
Self-citationNAD(P)H:quinone oxidoreductase1 (DT-diaphorase): expression, regulation, and role in cancer.
Joseph, P., Xie, T., Xu, Y., & Jaiswal, A. K. (1994) · PubMed · Cited by 92
Stiborová, M. (2002) · Carcinogenesis · doi:10.1093/carcin/23.4.617 · Cited by 88
Mutagenicity of aristolochic acid in the lambda/lacZ transgenic mouse (Muta™Mouse)
Kohara, A., Suzuki, T., Honma, M., Ohwada, T., & Hayashi, M. (2002) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00350-3 · Cited by 76
Tanaka, A., Nishida, R., Maeda, K., Sugawara, A., & Kuwahara, T. (2000) · PubMed · Cited by 74
Cosyns, J., Goebbels, R., Liberton, V., Schmeiser, H. H., Bieler, C. A., & Bernard, A. (1998) · Archives of Toxicology · doi:10.1007/s002040050568 · Cited by 69
New Treatment for Chronic Myelogenous Leukemia
Schwetz, B. A. (2001) · JAMA · doi:10.1001/jama.286.1.35 · Cited by 67
Puga, A., Nebert, D. W., McKinnon, R. A., & Menon, A. G. (1997) · Critical Reviews in Toxicology · doi:10.3109/10408449709021619 · Cited by 59
Vishwanath, B. S., Rao, A. G. A., & Gowda, T. V. (1987) · Toxicon · doi:10.1016/0041-0101(87)90156-5 · Cited by 59
Schmeiser, H. H., Scherf, H. R., & Wießler, M. (1991) · Cancer Letters · doi:10.1016/0304-3835(91)90178-k · Cited by 57
[End-stage renal insufficiency associated with Chinese herbal consumption in France].
Stengel, B., & Jones, E. (1998) · PubMed · Cited by 56
Pfau, W., Schmeiser, H. H., & Wießler, M. (1991) · Chemical Research in Toxicology · doi:10.1021/tx00023a015 · Cited by 55
Meyer, M. M., Chen, T.-P., & Bennett, W. M. (2000) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.2000.11927699 · Cited by 53
Krumme, B., Endmeir, R., Vanhaelen, M. H., & Walb, D. (2001) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/16.2.400 · Cited by 53
The Aristolochic Acids and Aristolactams
Shamma, M., & Moniot, J. L. (1978) · Springer eBooks · doi:10.1007/978-1-4615-8819-1_17 · Cited by 46
Outbreak of Chinese Herb Nephropathy in Japan: Are There Any Differences from Belgium?
TANAKA, A., Nishida, R., YOSHIDA, T., Koshikawa, M., Goto, M., & Kuwahara, T. (2001) · Internal Medicine · doi:10.2169/internalmedicine.40.296 · Cited by 46
Aristolochic acid-induced Fanconi's syndrome and nephropathy presenting as hypokalemic paralysis
Yang, S.-S., Chu, P., Lin, Y., Chen, A., & Lin, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.31425 · Cited by 45
Aristolochic acid is mutagenic and recombinogenic in Drosophila genotoxicity tests
Frei, H., Würgler, F. E., Juon, H., Hall, C. B., & Gräf, U. (1985) · Archives of Toxicology · doi:10.1007/bf00333420 · Cited by 44
Broschard, T. H., Wießler, M., von der Lieth, C., & Schmeiser, H. H. (1994) · Carcinogenesis · doi:10.1093/carcin/15.10.2331 · Cited by 43
On a nephrotoxic and carcinogenic slimming regimen
Broe, M. E. D. (1999) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(99)70159-9 · Cited by 37
Stiborová, M., Hájek, M., Frei, E., & Schmeiser, H. H. (2001) · PubMed · Cited by 37
Chen, W., Chen, Y., & Li, A. (2001) · PubMed · Cited by 35
[Chinese herbs nephropathy in the Kansai area: a warning report].
Tanaka, A., Shinkai, S., Kasuno, K., Maeda, K., Murata, M., Seta, K., Okuda, J., Sugawara, A., Yoshida, T., Nishida, R., et al. (1997) · PubMed · Cited by 34
Tanaka, A., Nishida, R., Sawai, K., Nagae, T., Shinkai, S., Ishikawa, M., Maeda, K., Murata, M., Seta, K., Okuda, J., et al. (1997) · PubMed · Cited by 34
Association of valvular heart disease with Chinese-herb nephropathy
Vanherweghem, J. (1997) · The Lancet · doi:10.1016/s0140-6736(05)63683-5 · Cited by 20
Stiborová, M., Hájek, M., Vošmiková, H., Frei, E., & Schmeiser, H. H. (2001) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc20010959 · Cited by 18
McIntyre, M. (1998) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1998.4.1-15 · Cited by 18
Malak, J., Singer, A., & Reid, B. (1998) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.1998.4.131 · Cited by 12
Cited by
A global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Aristolochic acid nephropathy: A worldwide problem
Debelle, F. D., Vanherweghem, J.-L., & Nortier, J. L. (2008) · Kidney International · doi:10.1038/ki.2008.129 · Cited by 763
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Grollman, A. P., Shibutani, S., Moriya, M., Miller, F., Wu, L., Moll, U., Suzuki, N., Fernandes, A., Rosenquist, T., Medverec, Z., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701248104 · Cited by 606
From traditional Chinese medicine to rational cancer therapy
Efferth, T., Li, P. C. H., Konkimalla, V. S. B., & Kaina, B. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.07.001 · Cited by 528
Kovacic, P., & Somanathan, R. (2014) · Journal of Applied Toxicology · doi:10.1002/jat.2980 · Cited by 510
Metadata
- Authors
- Arlt, V. M.
- Venue
- Mutagenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-07-01
- Volume
- 17
- Issue
- 4
- Pages
- 265-277
- ISSN
- 0267-8357 (ISSN-L)
- 1464-3804
- OpenAlex
- W2162463986
- Cited by
- 505
- References
- 54
- FWCI
- 12.45
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.